Skip to Content

Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%

August 19, 2026 by
Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%
OdooBot
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

Fuente original: 

in News
Sacked Ukrainian defence minister calls for presidential election
Portal Veterinario